Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy for management of cryptogenic stroke

Published by Ton Kuijpers, Fred Spencer, Reed Siemieniuk, Gordon Guyatt on Jul 26, 2018

View

Disclaimer

Sponsors

This guideline was not funded.

Contact

Abstract

A BMJ-Rapid Recommendation on patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy for management of cryptogenic stroke. This is the 10th BMJ-RapidRec, initiated in response to three recently published large trials in the New England Journal of Medicine (Mas 2017;377(11):1011-1021; Saver 2017;377(11):1022-1032; Søndergaard 2017;377:1033-42). Roles: Panel Chair: Fred Spencer Methods Editors: Ton Kuijpers Oversight from RapidRecs executive: Reed Siemieniuk, Thomas Agoritsas, Gordon Guyatt, Per Olav Vandvik Systematic Review Lead: Hassan Mir

Language

en

PICOS

PICO 20.1

Population
Patients with cryptogenic stroke ,
Intervention
PFO closure plus antiplatelet therapy ,
Comparator
Antiplatelet therapy ,
Outcomes
,

PICO 20.2

Population
Patients with cryptogenic stroke
Intervention
PFO closure plus antiplatelet therapy
Comparator
Anticoagulation
Outcomes

PICO 20.3

Population
Patients with cryptogenic stroke
Intervention
Anticoagulation
Comparator
Antiplatelet
Outcomes